TipRanks on MSN

Vertex and Moderna’s VX-522 Study: A Potential Breakthrough in Cystic Fibrosis Treatment

This study update could positively impact Vertex Pharmaceuticals and Moderna’s stock performance, as successful results may enhance their competitive position in the cystic fibrosis treatment market.
STAT

Advocacy groups form a buyer’s club to obtain generic versions of pricey Vertex cystic fibrosis drug

Frustrated by the price of a lifesaving cystic fibrosis treatment sold by Vertex Pharmaceuticals, a group of families is ...